Adductor Canal Block
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Osteoarthritis, Total Knee Replacement
In brief
The investigators aim to investigate whether the addition of a surgeon-administered adductor canal blockade to a multimodal periarticular injection cocktail provides additional pain relief for patients undergoing total knee arthroplasty. This study will help identify the effectiveness of surgeon-administered adductor canal blockade in perioperative pain control for patients undergoing total knee arthroplasty
Key facts
- Study ID
- NCT04513145
- Run by
- OrthoCarolina Research Institute, Inc.
- People needed
- 93
- Starts
- 2020-10-09
- Expected to finish
- 2025-05-23
- Last updated by the study team
- 2026-04-06
Who can join
Age: 30 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients age 30-85undergoing first-time primary unilateral total knee arthroplasty for osteoarthritis and remaining hospitalized for at least one night
You may not qualify if…
- Patients undergoing revision total knee arthroplasty
- Patients undergoing bilateral total knee arthroplasty
- Workers compensation patients
- Patients undergoing total knee arthroplasty for post-traumatic arthritis
- Patients with inflammatory arthritis
- Patients with any previous surgery on the operative knee which involved an arthrotomy
- Patients taking opioids prior to total knee arthroplasty
- Patients with a known history of drug or alcohol abuse
- Patients undergoing total knee arthroplasty at an ambulatory surgery center, or being discharged home from the hospital on the same day as their procedure (planned)
- Patients who have had a total knee arthroplasty performed on the contralateral knee
Where it is running
- OrthoCarolina Research Institute, OrthoCarolina, P.A. — Charlotte, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.